No risk association observed for anthracycline chemotherapy, cognitive decline in bre

[News]

New data analyses found no association between anthracycline chemotherapy and greater risk of cognitive decline in breast cancer survivors, according to an article published online by JAMA Oncology.

More... (http://www.medicalnewstoday.com/releases/309416.php)